Related Experiment Video
Updated: May 30, 2026
Isolation and In vitro Culture of Bone Marrow-Derived Macrophages for the Study of NO-Redox Biology
Published on: May 31, 2022
Cardamonin suppresses nitric oxide production via blocking the IFN-γ/STAT pathway in endotoxin-challenged peritoneal
Amane Takahashi1, Norio Yamamoto, Akira Murakami
1Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan.
Insights
Cardamonin, a flavonoid, effectively reduces nitric oxide (NO) production in inflammatory conditions by inhibiting the JAK/STAT pathway. This phytochemical shows promise as a novel anti-inflammatory agent.
Area of Science:
- Immunology and Pharmacology
- Natural Product Chemistry
Background:
- Overproduction of nitric oxide (NO) by inducible NO synthase (iNOS) is implicated in various inflammatory diseases.
- Flavonoids are natural compounds with potential anti-inflammatory properties.
- Understanding the molecular mechanisms of these compounds is crucial for therapeutic development.
Purpose of the Study:
- To investigate the effects of six flavonoids on lipopolysaccharide (LPS)-induced NO generation in macrophages.
- To elucidate the molecular mechanisms underlying the anti-inflammatory activity of cardamonin.
Main Methods:
- In vitro assays using LPS-stimulated macrophages to assess NO generation.
- In vivo evaluation of anti-inflammatory activity in LPS-challenged mice.
- Mechanistic studies involving ELISA, Western blot, and RT-PCR to analyze gene and protein expression.
Main Results:
- Cardamonin demonstrated significant suppressive activity on NO generation, outperforming curcumin.
- Cardamonin down-regulated iNOS mRNA expression and suppressed STAT-1 activation in macrophages.
- Cardamonin inhibited multiple STATs (1-4) and suggested the involvement of the JAK/STAT pathway in NO generation.
Conclusions:
- Cardamonin is a unique phytochemical that targets Interferon-gamma (IFN-γ) production.
- It suppresses the STAT pathway, offering a novel mechanism for mitigating inflammation.
- Cardamonin presents a promising therapeutic candidate for inflammatory diseases.
Aims:
Overproduction of nitric oxide (NO) from inducible NO synthase (iNOS) plays many pivotal roles in various inflammatory diseases. In this study, we examined the effects of 6 flavonoids on lipopolysaccharide (LPS)-induced NO generation in macrophage (Mφ), and addressed molecular mechanisms of cardamonin.
Main Methods:
Suppressive effects on NO generation in vitro were assayed in LPS-stimulated macrophages (Mφ). In vivo anti-inflammatory activity was evaluated with LPS-challenged ICR mice. Mechanistic analyses were done by ELISA, Western blot, RT-PCR, etc.
Key Findings:
Cardamonin, a chalcone, exhibited pronounced suppressive activity, while pinocembrin, a counterpart flavanone, was much less active. Administration of cardamonin (0.02-2 mg/kg body weight) significantly decreased NOx concentrations in the sera from LPS-challenged ICR mice. This efficacy was superior to that of curcumin, a well-known anti-inflammatory agent present in turmeric. Cardamonin down-regulated iNOS mRNA expression and suppressed activation of STAT-1, but not nuclear factor kappaB, both of which are transcription factors for the iNOS gene in peritoneal Mφ of ICR mice. Interferon (IFN)-γ was identified as the major cytokine which mediates LPS-induced STAT-1 activation and resultant iNOS expression. Intriguingly, cardamonin suppressed the activation of not only STAT-1 but also STATs-2, 3 and 4. The involvement of the JAK/STATs pathway in NO generation was suggested because its specific inhibitor, AG490, decreased NO generation.
Significance:
Cardamonin was identified to be a unique phytochemical that targets the production of IFN- and thereby suppresses the STAT pathway for mitigating inflammation.
